Predictors of elevated cardiac troponin T on admission in ST-segment elevation myocardial infarction

Annals of Clinical Biochemistry

Volumn 43, Issue 4, 2006, Pages 281-286

  Rasoul, Saman ^a   Nienhuis, Mark B ^a   Ottervanger, Jan Paul ^a   Slingerland, Robbert J ^a   De Boer, Menko Jan ^a   Dambrink, Jan Henk E ^a   Ernst, Nicolette M ^b   Hoorntje, Jan C A ^a   Gosselink, A T Marcel ^a   Suryapranata, Harry ^c   Zijlstra, Felix ^c   Van't Hof, Arnoud W J ^a  

^a ISALA HOSPITAL   (Netherlands)

^b Department of Clinical Chemistry ^*  (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; LACTATE DEHYDROGENASE; TIROFIBAN; TROPONIN T;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY STENT; ELECTROCARDIOGRAM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REPERFUSION; ST SEGMENT ELEVATION; SYMPTOM;

AGED; CHEMISTRY, CLINICAL; CORONARY ANGIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; PROGNOSIS; TREATMENT OUTCOME; TROPONIN T;

EID: 33745924677     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456306777695627     Document Type: Article

References (20)

1. Ohman EM, Topol EJ, Califf RM, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335: 1333-41
2. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation 1996; 94: 1291-7
3. Ohman EM, Armstrong PW, White HD, et al. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. Am J Cardiol 1999; 84: 1281-6
4. Giannitsis E, Lehrke S, Wiegand UK, et al. Risk stratification in patients with inferior acute myocardial infarction treated by percutaneous coronary interventions: the role of admission troponin T. Circulation 2000; 102: 2038-44
5. Matetzky S, Sharir T, Domingo M, et al. Elevated troponin I level on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction. Circulation 2000; 102: 1611-6
6. Giannitsis E, Muller-Bardorff M, Lehrke S, et al. Admission Troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction. Circulation 2001; 104: 630-5
7. Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902-12
8. van 't Hof AWJ, Ernst N, de Boer MJ, et al., on behalf of the On-TIME study group. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the Ongoing Tirofiban in Myocardial Infarction Evaluation (On-TIME) trial. Eur Heart J 2004; 25: 837-46
9. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000; 102: 2031-7
10. Van 't Hof AWJ, Liem A, Suryapranata H, Hoorntje JCA, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 1998; 97: 2302-6
11. Rittersma SZ, van der Wal AC, Koch KT, et al. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 2005; 111: 1160-5
12. De Luca G, van 't Hof AWJ, de Boer MJ, et al. Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for STsegment-elevation myocardial infarction and signs of heart failure. Circulation 2004; 109: 958-61
13. Frostfeldt G, Gustafsson G, Lindahl B, Nygren A, Venge P, Wallentin L. Possible reasons for the prognostic value of troponin-T on admission in patients with ST-elevation myocardial infarction. Coron Artery Dis 2001; 12: 227-37
14. Henriques JPS, Zijlstra F, Ottervanger JP, et al. Angiographic predictors of left ventricular ejection fraction after successful angioplasty in acute myocardial infarction: an angiographic risk score for use in the catheterization laboratory. Catheter Cardiovasc Interv 2004; 61: 338-43
15. Stone GW, Cox D, Garcia E, et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction. Analysis from the Primary Angioplasty in Myocardial Infarction Trials. Circulation 2001; 104: 636-41
16. Zeymer U, Vogt A, Tebbe U, Neuhaus KL. Influence of infarct location on the prognostic impact of Thrombolysis in Myocardial Infarction (TIMI) perfusion grade of the infarct-related artery after thrombolysis for acute myocardial infarction. J Clin Basic Cardiol 2000; 3: 43-5
17. Panteghini M, Cuccia C, Bonetti G, Giubbini R, Pagani F, Bonini E. Single-point cardiac troponin T at coronary care unit discharge after myocardial infarction correlates with infarct size and ejection fraction. Clin Chem 2002; 48: 1432-6
18. Kurowski V, Hartmann F, Killermann DP, et al. Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percutaneous interventions for acute ST-segment elevation myocardial infarction. Crit Care Med 2002; 30: 2229-35
19. Stone GW, Grines CL, Cox DA, et al. Controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002; 346: 957-66
20. Cannon CP, Weintraub WS, Demopoulos LA, et al. TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy) - Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344: 1879-87